Clinical trials
Observational Breast Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 13 |
| Recruiting | 7 |
| Terminated | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sysmex America, Inc. | 4 |
| Ma Zhe | 3 |
| State University of New York - Upstate Medical University | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Antalya Training and Research Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| B.P. Koirala Institute of Health Sciences | 1 |
| Cairo University | 1 |
| Concure Oncology-Breast Microseed Inc. | 1 |
| Endeavor Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Diseases | 49 |
| Breast Neoplasms | 28 |
| Neoplasms | 5 |
| Cystic Fibrosis | 4 |
| Neoplasm Metastasis | 4 |
| Fibroadenoma | 3 |
| Neoplasms by Site | 3 |
| Mastodynia | 2 |
| Skin Diseases | 2 |
| Breast Neoplasms, Male | 1 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.